Multicenter Uveitis Steroid Treatment (MUST) Trial

Key facts

Sponsor

JHSPH Center for Clinical Trials

Principal Investigator

Douglas Jabs, MD, MBA

Icahn School of Medicine at Mount Sinai

Intervention

fluocinolone acetonide intraocular implant(drug)

Enrollment

255 enrolled

Eligibility

13 years · All sexes

Timeline

2005 – 2010

Study locations (23)

• Jacobs Retina Center, UCSD, La Jolla, California, United States
• Doheny Eye Institute, USC, Los Angeles, California, United States
• Jules Stein Eye Institute, UCLA, Los Angeles, California, United States
• Proctor Foundation, UCSF, San Francisco, California, United States
• Anne Bates Leach Eye Hospital, University of Miami Miller School of Medicine, Miami, Florida, United States
• University of South Florida, Tampa, Florida, United States
• Emory University, Atlanta, Georgia, United States
• Rush University Medical Center, Chicago, Illinois, United States
• University of Illinois at Chicago Eye Center, Chicago, Illinois, United States
• Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, United States
• National Eye Institute, NIH, Bethesda, Maryland, United States
• Massachusetts Eye Research & Surgery Institute, Cambridge, Massachusetts, United States
• Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States
• Barnes Retina Institute, St Louis, Missouri, United States
• New York Eye and Ear Infirmary, New York, New York, United States
• +8 more locations on ClinicalTrials.gov

Collaborators

National Eye Institute (NEI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.